How risky can the weight-loss drug boom be? I learned the hard way.
Unregulated copycat versions of GLP-1s are a dangerous blind spot.
Jimmie Wilson is president of the JADA Foundation.
Millions of Americans have increasingly turned to GLP-1 medications to lose weight and improve their health. These drugs have transformed treatment for obesity and diabetes and helped countless patients. But their popularity has also fueled a thriving market for unregulated copycat versions.
Most patients have no idea how risky these knockoff drugs can be. I learned the hard way…
Read more at: https://www.washingtonpost.com/opinions/2026/03/31/weight-loss-compounding-pharmacies/